About Us2024-11-25T15:04:46-05:00

About Us

Clinilabs is the only global, full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug development. With deep expertise in CNS, we are committed to the development of medicines that treat a range of psychiatric, neurological, and substance use disorders, as well as rare and ultra-rare CNS diseases. Clinilabs partners with pharmaceutical and biotechnology companies to deliver a complete, first-in-human to Phase 3 spectrum of high-quality, timely, and cost-effective clinical drug development services, with the shared goal of speeding new CNS medicines to market. We are process-driven yet structured to be nimble, providing personalized service that meets the needs of customers and projects of all sizes. Clinilabs has conducted more than 750 CNS clinical trials since 2000 and has played a pivotal role in approving 22 new therapies across 13 CNS indications to help transform patients’ lives worldwide.

Our Mission

Clinilabs’ mission is to provide high-quality, prompt, and cost-effective drug and device development services to its clients in the interest of delivering new therapeutics to those in need.

Our vision is to become the leading CRO dedicated to providing CNS drug development services.

Our Vision

Clinilabs’ vision is to become the leading contract research organization (CRO) dedicated to providing CNS clinical development services.

We aspire to a

Our Culture

Clinilabs aspires to a “culture of quality” in which all our decisions and actions represent our dedication to quality in clinical development and health care.

Volunteers

We empower study participants through informed decisions regarding study participation.

Investigators

Clinilabs offers a full range of Phase I, II and III clinical development services.

Go to Top